Not exact matches
Fiers discovered a key protein on the influenza virus that could serve as a target for a universal
vaccine; the drug has shown
promise in an early clinical
trial.
The recent phase 2 STEP
trial of the HIV
vaccine (V520) showed disappointing results, but another
vaccine made by GeoVax will be moving into phase 2 clinical
trials in the next few months based on
promising phase 1 results.
To be sure, scientists have zeroed in on some
promising vaccine - adjuvant combinations, and a few well - designed
trials are now under way.
A malaria
vaccine, made by GlaxoSmithKline, is in clinical
trials, and a 2011 paper reported
promising results, showing that it seemed to protect about half of the kids who received it.
«However, the
promising results of this
trial lay the foundations for the development of a more cost - effective, clinically - practical
vaccine technology that could deliver similar outcomes for patients.
«World's most advanced dengue
vaccine candidate shows
promise in phase 3
trial.»
A new type of cancer
vaccine has yielded
promising results in an initial clinical
trial conducted at the Perelman School of Medicine at the University of Pennsylvania and the Abramson Cancer Center of the University of Pennsylvania.
«Personalized tumor
vaccine shows promise in pilot trial: Vaccine against patients» own tumors triggers a broad response, and induced five - year remission in one patient with advanced ovarian cancer.
vaccine shows
promise in pilot
trial:
Vaccine against patients» own tumors triggers a broad response, and induced five - year remission in one patient with advanced ovarian cancer.
Vaccine against patients» own tumors triggers a broad response, and induced five - year remission in one patient with advanced ovarian cancer.»
«Many adenovirus
vaccine trials are moving forward for HIV, malaria and TB with
promising results and very few residual safety concerns,» he said.
«We observed rapid and durable protective immunity without adverse events, and so we think this candidate
vaccine represents a
promising strategy for the global fight against Zika virus,» said senior author Drew Weissman, MD, PhD, a professor of Infectious Disease at Penn. «We hope to start clinical
trials in 12 to 18 months.»
«
Vaccine against respiratory syncytial virus shows
promise in early
trial: Researchers describe a new approach to developing RSV
vaccines, reporting
promising early results in young children.»
Candidate Zika
vaccines, which have shown early
promise, should be in clinical
trials next year.
Several drugs and
vaccines have shown
promise in nonhuman primates, but none of them have successfully made it through phase I human
trials.
Scientists have many
promising malaria
vaccine candidates in the works, and for the first time one has reached advanced human
trials.
Vaccine trials started last week, and initial observations are
promising, but Donnelly and her team warn that it will take many months to scale up production sufficiently to start having an effect on the current epidemic.
«Prime - boost H7N9 influenza
vaccine concept
promising in clinical
trial.»
Activists often slam large pharmaceutical companies for failing to develop drugs that are of critical importance to the developing world.Andrew Witty, GlaxoSmithKline's youthful chief executive, gave those critics pause yesterday in a speech to the Council on Foreign Relations in New York City.Witty
promised to sell the company's malaria
vaccine that is in late - stage clinical
trials in Africa for no more than a 5 percent profit.
After all the work of planning, funding and getting approval for a
vaccine trial in humans, «you're talking at least about three years in a best - case scenario, if you have a very
promising product,» said Matthew Laurens, an associate professor of pediatrics and medicine at the University of Maryland who was not associated with the study.
Clinical
trials for several
vaccines are in various phases, with
promising published results in humans.
With enthusiasm for cancer immunotherapy mounting thanks to recent successes in the clinic with immune - based cancer treatments such as anti-CTLA-4 and anti-PD-1 antibodies, and the FDA approvals of sipuleucel - T prostate cancer
vaccine and ipilimumab for the treatment of melanoma, and in light of the many
promising immunotherapies now in clinical
trials with potential for near - term FDA approval, the Cancer Research Institute launched the first annual Cancer Immunotherapy Awareness Month in June 2013 as a way to increase public awareness of the power of immunotherapy to revolutionize cancer treatment and of the need for continued public support for research to bring these treatments to more patients sooner.
About 15 years ago, he led
trials at pharmaceutical giant Merck on an especially
promising vaccine — «the best hope we had,» Kim recalled — that ultimately failed.
A malaria
vaccine has shown
promising results in early stage clinical
trials, a study suggests.
Professor Ruth Karron answers a few questions about why findings from a new
vaccine trial she led are so
promising.
PD01A:
Promising Animal Efficacy; Initial Human Safety and Hints of Disease Modification At the time of our last post on α - synuclein
vaccines, AFFiRiS had published several papers about the AFFITOME immnotherapy discovery platform [8 - 11] and had even begun their first Phase I
trial of PD01A, but had kept nearly silent on many of the most elementary aspects of the
vaccine.
WCBS 880 AM — A «
Promising Lead» in Fight Against Pancreatic Cancer - April 4, 2012 Early results from a clinical
trial at CINJ show stable disease in pancreatic cancer for certain candidates following
vaccine treatment.
«This study allowed us to evaluate the protective efficacy of several prime - boost
vaccine combinations, and these data will help guide the advancement of the most
promising candidates into clinical
trials,» noted lead author Dr. Dan Barouch of Beth Israel Deaconess Medical Center at Harvard Medical School and the Ragon Institute of MGH, MIT, and Harvard.
All eyes are on a new BCG - based TB
vaccine, VPM1002, which has shown
promise in animal and small - scale human
trials.
A good knowledge of correlates of protection could predict the efficacy of novel
vaccines at early stages of development and help identify the most
promising candidates for
vaccine trials.
Four other
trials in humans are launching in the upcoming months, and the
vaccine has already shown
promising results in animals.
The second phase of clinical
trials for a new
vaccine is complete and the results are very
promising.
That's why I'm so happy to report the news that an anti-malaria
vaccine known as RTS, S (aka Mosquirix) is in the final stage of clinical
trial and shows great
promise.